News

Department of Biocommunication Development Relocates to Kyoto University

biozipadmin2026-05-12T17:19:19+09:00May 12, 2026|Information|

Announcement of Capital Increase (Capital: 70 Million Yen)

biozipadmin2024-04-23T12:37:29+09:00April 3, 2024|Information|

About the establishment of Biozipcode, Inc.

biozipadmin2024-06-19T14:19:06+09:00December 1, 2023|Information|

Visiting Ambassador Hiroi Orikasa at the Embassy of Japan in Palau

biozipadmin2024-01-27T12:07:50+09:00November 17, 2023|Information|

A research paper titled “Diabetes can be completely cured” was published in the scientific journal “Communications Biology”

biozipadmin2024-01-27T12:41:53+09:00June 13, 2023|Research|

Notice Regarding Changes in Shareholders and Board Members

biozipadmin2024-01-27T11:59:01+09:00January 24, 2023|Information|

Announcement of Dr. Hideto Kojima’s Seminar – ‘Saying Goodbye to Diabetes!’

biozipadmin2024-01-27T11:50:39+09:00December 12, 2022|Information|

Announcement of Business Collaboration with Co-LABO MAKER, a Venture Company Originating from Tohoku University.

biozipadmin2024-01-27T11:43:15+09:00December 6, 2022|Information|

Biozipcode, Inc. exhibited at ‘BioJapan2022’

biozipadmin2024-01-27T11:29:21+09:00September 20, 2022|Information|

Announcement of Commencement of Advisory Services for Diabetes and Regenerative Medicine

biozipadmin2024-01-27T11:27:11+09:00September 12, 2022|Research|

Biozipcode, Inc.

We aim to completely cure diseases rather than just offering symptomatic treatments. We focus on developing a cure for diabetes and a technology that delivers medication to specific cells (cell targeting technology called “Biozipcode”).

Learn More About Us

Contact Us

Biozipcode, Inc.

TEL:
+81-50-5534-7865

E-MAIL:
info@biozipcode.com

ADDRESS:
6-2-6 Kojimachi, Chiyoda-ku, Tokyo 102-0083, PMO Kojimachi, 8th Floor.

Languages

© Copyright 2026 Biozipcode, Inc. All Rights Reserved.